BioFactor Therapeutics

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Acquired | Acquired

About BioFactor Therapeutics

Developer of novel pharmaceutical approaches for the treatment of gastrointestinal disorders. The company's research is currently focussed around a proprietary bioactive peptide that has demonstrated antisecretory effects in animals and human healthy volunteers.

BioFactor Therapeutics Headquarter Location

Stockholm,

Sweden

46 8 442 58 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.